Skip to content

Effect of daily ingestion of Kishu plum ( Prunus mume) on arteriosclerosis and lipid metabolism: a double-blind, placebo-controlled, parallel group comparison study.

Effect of daily ingestion of Kishu plum ( Prunus mume) on arteriosclerosis and lipid metabolism: a double-blind, placebo-controlled, parallel group comparison study. - Beneficial Effects of Daily Ingestion of Kishu plum on Arteriosclerosis and Lipid Metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020201
Enrollment
52
Registered
2015-12-15
Start date
2015-12-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Ingestion of 35g of paste made from &quot
Kishu plum treated with superheated steam&quot
daily for 12 weeks. Ingestion of 35g of &quot
pickled plum&quot
paste daily for 12 weeks.

Sponsors

Hokkaido Information University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects whose arteriosclerosis index is >=1.5. 2. Subjects who agree to participate in the current study with a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects who are under treatmentand medication for hyperlipidemia and diabetes. 2. Subjects with familial hypercholesterolemia. 3. Subjects whose LDL-C is >=180 mg/dl. 4. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, disorder of endocrine and metabolism or affected with infectious diseases which are required to report to the authorities. 5. Subjects who have a major surgical history related to digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 6. Subjects with unusually high and/or low blood pressure or abnormal hematological data. 7. Subjects with serious anemia. 8. Pre- or post-menopausal women having obvious changes in physical condition. 9. Subjects who are at risk of having allergic reactions to drugs or foods (especially plum and agar). 10. Subjects who regularly take drugs, functional foods and/or supplements (EPA, DHA, MCT, phytosterol, sesamin, turmeric, polyphenols, dietary fiber, etc.) which would affect the blood lipid levels. 11. Subjects who regularly take drugs, functional foods and/or supplements (containing dietary fiber such as indigestible dextrin, polyphenol, etc.) which would affect blood glucose. 12. Heavy smokers, alcohol addicts or subjects with irregular lifestyle 13. Subjects who donate either 400ml whole blood within 12 weeks or 200ml whole blood within 4 weeks or blood components within 2 weeks prior to this study. 14. Pregnant or lactating women or women expect to be pregnant during the clinical trial. 15. Subjects who participate in other clinical trials within the last one month prior to this study. 16. Any other medical reasons judged by the principal investigator

Design outcomes

Primary

MeasureTime frame
Arteriosclerosis Index, TC, LDL-C, HDL-C and TG at 4, 8 and 12 weeks after the beginning of ingestion of test meals.

Secondary

MeasureTime frame
oxo-LDL, TBARS, VAS questionnaire for lassitude and defecation, frequency of bowel movement, body composition (BW, BFR, BMI)

Countries

Japan

Contacts

Public ContactDir. Prof. Jun NISHIHIRA, M.D., Ph.D.

Hokkaido Information University Center of Health Information Science

nishihira@do-johodai.ac.jp011-385-4430

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026